GlcNAcstatins are nanomolar inhibitors of humanO-GlcNAcase inducing cellular hyper-O-GlcNAcylation

Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity

(2008) Ronald J. Copeland et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury

(2008) Dongqi Xing et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Chemical Dissection of the Link between Streptozotocin, O-GlcNAc, and Pancreatic Cell Death

(2008) Shalini Pathak et al.   CHEMISTRY & BIOLOGY

Molecular mechanisms of O-GlcNAcylation

(2008) Ramon Hurtado-Guerrero et al.   CURRENT OPINION IN STRUCTURAL BIOLOGY

Protein ubiquitination is modulated by O-GlcNAc glycosylation

(2008) Céline Guinez et al.   FASEB JOURNAL

Elevation of GlobalO-GlcNAc Levels in 3T3-L1 Adipocytes by Selective Inhibition ofO-GlcNAcase Does Not Induce Insulin Resistance

(2008) Matthew S. Macauley et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo

(2008) Scott A Yuzwa et al.   Nature Chemical Biology

Antisense glutaminase inhibition modifies the O-GlcNAc pattern and flux through the hexosamine pathway in breast cancer cells

(2007) Ana C. Donadio et al.   JOURNAL OF CELLULAR BIOCHEMISTRY